Prevention of Hepatic Malignancies

A new antigen/adjuvant combination for the prevention of hepdnaviruses-related complications of transplantation (graft infections), in-licensed.

Overview of the current clinical development programme

• Clinical lots and release
• Phase III trials (4 studies, 2005 – 2009)
• Out-licensing of distribution rights, after market authorization
• Royalties